老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Iovance Biotherapeutics, Inc.

9.53
+0.17001.82%
成交量：1,353.55萬
成交額：1.31億
市值：43.17億
市盈率：-13.50
高：9.92
開：9.45
低：9.44
收：9.36
52周最高：9.92
52周最低：1.76
股本：4.53億
流通股本：3.94億
量比：1.12
換手率：3.44%
股息：- -
股息率：- -
每股收益(TTM):-0.7058
每股收益(LYR):-1.0941
淨資產收益率：-40.36%
總資產收益率：-20.31%
市淨率：5.86
市盈率(LYR):-8.71

資料載入中...

總覽公司新聞資訊公告
2020/05/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/25

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/24

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/09/20

SEC問詢函

[Cover]Correspondence
2019/09/17

SEC問詢函

[Cover]Correspondence
2019/08/01

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/01

重要事件披露

Current report, items 2.02 and 9.01
2019/07/19

持股變動聲明

Initial statement of beneficial ownership of securities
2019/07/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/02

重要事件披露

Current report, items 8.01 and 9.01
更多